Please login to the form below

Not currently logged in
Email:
Password:

Chinese dietary supplements contain Viagra API

Several Chinese manufactured dietary supplements are found to contain sildenafil, the active ingredient found in Pfizer's sexual dysfunction drug Viagra, says the FDA

The FDA has warned that several Chinese manufactured dietary supplements contain sildenafil, the active ingredient found in Pfizer's sexual dysfunction drug Viagra, and could be harmful to consumers.

In a statement on its website on 1 January 2008, the FDA said it was advising consumers not to buy or use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular products.

The FDA added that the products, which originated in China, were being marketed for the treatment of erectile dysfunction and for sexual enhancement.

None of the product labels mention that they contain sildenafil or a similar compound, the agency added.

The FDA warned that the undeclared ingredients in these products may interact with nitrates found in some prescription drugs and can lower blood pressure to dangerous levels. Particularly at risk are sufferers of diabetes, high blood pressure, high cholesterol or heart disease.

The products, which were distributed in the US by a company based in Puerto Rico, have not been approved by the FDA and are illegal.

2nd January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics